Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17100941rdf:typepubmed:Citationlld:pubmed
pubmed-article:17100941lifeskim:mentionsumls-concept:C0033117lld:lifeskim
pubmed-article:17100941lifeskim:mentionsumls-concept:C1318700lld:lifeskim
pubmed-article:17100941lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:17100941lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:17100941lifeskim:mentionsumls-concept:C0679717lld:lifeskim
pubmed-article:17100941lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:17100941pubmed:issue6lld:pubmed
pubmed-article:17100941pubmed:dateCreated2006-11-14lld:pubmed
pubmed-article:17100941pubmed:abstractTextRecurrent ischemic priapism is an enigmatic erectile disorder in need of improved clinical interventions to avert its known, potentially serious complications.lld:pubmed
pubmed-article:17100941pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17100941pubmed:languageenglld:pubmed
pubmed-article:17100941pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17100941pubmed:citationSubsetIMlld:pubmed
pubmed-article:17100941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17100941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17100941pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17100941pubmed:statusMEDLINElld:pubmed
pubmed-article:17100941pubmed:monthNovlld:pubmed
pubmed-article:17100941pubmed:issn1743-6095lld:pubmed
pubmed-article:17100941pubmed:authorpubmed-author:BurnettArthur...lld:pubmed
pubmed-article:17100941pubmed:authorpubmed-author:BivalacquaTri...lld:pubmed
pubmed-article:17100941pubmed:authorpubmed-author:MusickiBiljan...lld:pubmed
pubmed-article:17100941pubmed:authorpubmed-author:ChampionHunte...lld:pubmed
pubmed-article:17100941pubmed:issnTypePrintlld:pubmed
pubmed-article:17100941pubmed:volume3lld:pubmed
pubmed-article:17100941pubmed:ownerNLMlld:pubmed
pubmed-article:17100941pubmed:authorsCompleteYlld:pubmed
pubmed-article:17100941pubmed:pagination1077-84lld:pubmed
pubmed-article:17100941pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:meshHeadingpubmed-meshheading:17100941...lld:pubmed
pubmed-article:17100941pubmed:year2006lld:pubmed
pubmed-article:17100941pubmed:articleTitleFeasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.lld:pubmed
pubmed-article:17100941pubmed:affiliationJohns Hopkins University-Urology, Baltimore, MD, USA. aburnett@jhmi.edulld:pubmed
pubmed-article:17100941pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17100941lld:pubmed